Article
Inhibition of p70 S6 kinase (S6K1) activity by A77 1726, the active metabolite of leflunomide, induces autophagy through TAK1-mediated AMPK and JNK activation.
Oncotarget - 2 May 2017
Xu Xiulong, Sun Jing, Song Ruilong, Doscas Michelle E, Williamson Ashley J, Zhou Jingsong, Sun Jun, Jiao Xinan, Liu Xiufan, Li Yi
Abstract excerpt
mTOR activation suppresses autophagy by phosphorylating ULK1 at S757 and suppressing its enzymatic activity. Here we report that feedback activation of mTOR in the PI-3 kinase pathway by two p70 S6 kinase (S6K1) inhibitors (PF-4708671 and A77 1726, the active metabolite of an immunosuppressive drug leflunomide) or by S6K1 knockdown did not suppress but rather induced autophagy. Suppression of S6K1 activity led to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.